Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: Implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction

Cancer

Volumn 94, Issue 3, 2002, Pages 820-831

  Shen, Bo ^a   Ormsby, Adrian H ^a   Shen, Chen ^b   Dumot, John A ^a   Shao, Yun Wei ^b   Bevins, Charles L ^a   Gramlich, Terry L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Qidong City Hospital   (China)

Author keywords

Barrett esophagus; Cytokeratins; Gastric carcinoma; Helicobacter pylori; Intestinal metaplasia

Indexed keywords

CYTOKERATIN; CYTOKERATIN 20; CYTOKERATIN 7;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CARDIA; CHINESE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC BIOPSY; ESOPHAGUS CANCER; EVALUATION; FEMALE; HELICOBACTER PYLORI; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; INTESTINE METAPLASIA; INTESTINE MUCOSA; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; STOMACH EPITHELIUM;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; ENDOSCOPY; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELICOBACTER INFECTIONS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; INTESTINES; KERATIN-20; MALE; METAPLASIA; MIDDLE AGED; PHENOTYPE; RISK FACTORS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036468744     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10215     Document Type: Article

References (35)

1. Dysplasia in short segment Barrett's esophagus: A prospective 3-year follow-up
2. Long-term follow-up of intestinal metaplasia of the gastric cardia
3. Prevalence of metaplasia at the gastro-esophageal junction
4. Intestinal metaplasia at the gastrooesophageal junction: Helicobacter pylori gastritis or gastrooesophageal reflux disease?
5. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: Prevalence and clinical data
6. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic endoscopy
7. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus
8. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
9. Adenocarcinoma in Barrett's esophagus: A new epidemic?
10. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction
11. The decline in gastric cancer: Epidemiology of an unexplained triumph
12. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites
13. Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985
14. The time trend and age-period-cohort effects on incidence of adenocarcinoma of the stomach in Connecticut from 1955-1990
15. Stomach cancer: Major trends in incidence during introduction of gastroscopy service in Norway
16. Descriptive epidemiology of adenocarcinoma of the cardia and distal stomach in the Swiss canton of Vaud
17. Changes in the site and histology-specific incidence of gastric cancer during a 50-year period
18. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
19. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells
20. Cytokeratins in the histological diagnosis of malignant tumor
21. Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues
22. Cytokeratin 20 in human carcinomas: A new histodiagnostic marker detected by monoclonal antibodies
23. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas
24. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach
25. Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: An immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45MI
26. The utility of cytokeratin subsets in distinguishing Barrett's-related oesophageal adenocarcinoma from gastric adenocarcinoma
27. Geshwulste res magen und duodenumums
28. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma: An attempt at a histo-chemical classification
29. The sensitivity and specificity of histologic features in the diagnosis of Barrett's esophagus on routine endoscopic biopsy specimens
30. Inter-institutional variability in the interpretation of cytokeratin7/20 (CK7/20) staining patterns in Barrett's esophagus (BE)
31. Cytokeratin 7 and 20 in the diagnosis of Barrett's esophagus (BE) with and without dysplasia
32. Cytokeratin 20 immunostaining decreases from dysplasia to invasive carcinoma in Barrett's oesophagus
33. Immunohistochemical markers for Barrett's esophagus and associations to esophageal Z-line appearance
34. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens
35. Histogenetical investigations on adenocarcinomas of the esophagogastric junction: An immunohistochemical study